Scarica l'app Stockscreener
4.96
1.78%
-0.09
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BHC Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$5.05
Aprire:
$5.1
Volume 24 ore:
2.06M
Relative Volume:
0.88
Capitalizzazione di mercato:
$1.84B
Reddito:
$10.27B
Utile/perdita netta:
$120.00M
Rapporto P/E:
11.97
EPS:
0.4142
Flusso di cassa netto:
$949.99M
1 W Prestazione:
-7.81%
1M Prestazione:
-17.20%
6M Prestazione:
-31.68%
1 anno Prestazione:
-28.01%
Intervallo 1D:
$4.93
$5.10
Intervallo di 1 settimana:
$4.93
$5.45
Portata 52W:
$4.25
$8.685
Bausch Health Companies Inc Stock (BHC) Company Profile
Nome
Bausch Health Companies Inc
Settore
Telefono
514-744-6792
Indirizzo
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Compare BHC vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
4.96 | 1.84B | 10.27B | 120.00M | 949.99M | 0.4142 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.77 | 56.14B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
115.62 | 48.81B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.03 | 44.67B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.57 | 33.27B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
536.12 | 23.50B | 3.18B | 1.33B | 1.04B | 27.90 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Equal Weight |
| 2024-08-02 | Downgrade | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | Iniziato | Raymond James | Mkt Perform |
| 2023-09-20 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-06-16 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | Downgrade | Truist | Buy → Hold |
| 2022-07-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-06-13 | Ripresa | JP Morgan | Overweight |
| 2021-03-24 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-02-17 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2020-08-24 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-17 | Reiterato | H.C. Wainwright | Buy |
| 2020-04-24 | Iniziato | Citigroup | Buy |
| 2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-12-02 | Iniziato | Goldman | Neutral |
| 2019-10-25 | Iniziato | Cowen | Outperform |
| 2019-09-12 | Iniziato | Guggenheim | Buy |
| 2019-08-15 | Aggiornamento | TD Securities | Hold → Buy |
| 2019-07-19 | Iniziato | Wolfe Research | Outperform |
| 2019-06-11 | Ripresa | Barclays | Overweight |
| 2019-05-13 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2019-03-20 | Iniziato | SunTrust | Buy |
| 2019-01-02 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | Aggiornamento | Piper Jaffray | Underweight → Neutral |
Mostra tutto
Bausch Health Companies Inc Borsa (BHC) Ultime notizie
Zacks Research Expects Lower Earnings for Bausch Health Cos - MarketBeat
Zacks Research Has Pessimistic View of TSE:BHC Q1 Earnings - MarketBeat
Growth Value: Is Bausch Health Companies Inc impacted by rising ratesRecession Risk & Safe Entry Point Alerts - baoquankhu1.vn
Bausch Health Companies (TSE:BHC) Stock Price Down 1.1%Here's What Happened - MarketBeat
Bausch Health to redeem ~$602M of outstanding notes due 2026 - MSN
How analysts rate Bausch Health Companies Inc. stock todayAnalyst Upgrade & Step-by-Step Trade Execution Guides - Naître et grandir
Vanguard Group Inc. Has $78.81 Million Stock Holdings in Bausch Health Cos Inc. $BHC - MarketBeat
Bausch Health expects 3% revenue growth in 2026 while strengthening balance sheet and expanding in China - MSN
BHC SEC FilingsBausch Health Companies Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Bausch Health (NYSE: BHC) CFO reports tax-withholding share disposition - Stock Titan
Bausch Health (BHC) EVP Carson trades shares, settles equity awards - Stock Titan
Tax withholding and cash PSU settlement for Bausch Health (BHC) CEO - Stock Titan
Seana Carson reports sales of 8,388 and 6,856 shares — BHC (NYSE: BHC) - Stock Titan
Bausch Health updates executive compensation agreements to cash settlement for 2023 PSUs - Investing.com Canada
Bausch Health updates executive compensation agreements to cash settlement for 2023 PSUs By Investing.com - Investing.com Australia
Bausch Health (NYSE: BHC) converts 2023 executive PSUs into cash-settled awards - Stock Titan
Bausch Health (NYSE:BHC) Stability Story Amid Canada Pharma Shifts Nyse Composite Today - Kalkine Media
Proposed insider sale at BHC (NYSE: BHC) — 6,856 common shares - Stock Titan
Bausch Health Cos Inc. (NYSE:BHC) Receives Average Rating of "Reduce" from Analysts - MarketBeat
Bausch Health Marks Arestin Milestone And Highlights Niche Dental Opportunity - Sahm
Is Bausch Health (BHC) Pricing Reflect Its Sharp Multi‑Year Share Price Declines? - Sahm
Assessing Bausch Health (BHC) Valuation After Years Of Weak Returns And Ongoing Debt Reduction Efforts - Sahm
Bausch Health (BHC) SVP Steven Lee receives 45,868 restricted share units - Stock Titan
Bausch Health (NYSE: BHC) EVP receives RSU grant, tax shares withheld - Stock Titan
Insider moves at Bausch Health (BHC): RSU grant, tax shares, open-market sale - Stock Titan
Bausch Health (NYSE: BHC) CFO awarded RSUs; shares withheld for tax obligations - Stock Titan
[144] Bausch Health Companies Inc. SEC Filing - Stock Titan
Should Bausch Health’s Profit Return and 2026 Outlook Shift the Investment Case for BHC? - Yahoo Finance
BHC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Bausch Health Cos (NYSE:BHC) Price Target Cut to $7.00 by Analysts at Barclays - MarketBeat
Signal Recap: Is now the right time to enter SAIAQuarterly Market Summary & Daily Entry Point Trade Alerts - baoquankhu1.vn
EV Market: Is Bausch Health Companies Inc backed by strong institutional buyingMarket Volume Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a 31.39% Potential Upside for Savvy Investors - DirectorsTalk Interviews
Trading Recap: Is Bausch Health Companies Inc stock a value trapJuly 2025 Gainers & Free Community Consensus Stock Picks - baoquankhu1.vn
Separation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook - Insider Monkey
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada - PR Newswire
New anti-aging laser lets Canadian clinics target wrinkles, spots, pores - Stock Titan
Bausch Health Weighs China Aesthetics Push Against ARESTIN Milestone And Debt - Yahoo Finance
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch Health Companies (BHC), Fennec Pharmaceuticals (FENC) and InfuSystem Holdings (INFU) - The Globe and Mail
Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now? - sharewise.com
Analysts Offer Insights on Healthcare Companies: KalVista Pharmaceuticals (KALV), Bausch Health Companies (BHC) and Insulet (PODD) - The Globe and Mail
Bausch Health Companies Inc. (NYSE:BHC) Q4 2025 Earnings Call Transcript - Insider Monkey
Can Bausch Health Companies Inc expand into new markets2025 Trade Ideas & Weekly Sector Rotation Insights - baoquankhu1.vn
Bausch Health revenue by segment 2021-2024 - Statista
Bausch + Lomb Q4 Earnings Review: Still A Buy, With Some Caveats (NYSE:BLCO) - Seeking Alpha
BHC Stock Down on Q4 Earnings Miss, Salix Drives Revenue Growth - Finviz
Bausch Health Cos (NYSE:BHC) Shares Gap DownTime to Sell? - MarketBeat
How Bausch Health’s Turnaround Progressed In Q4 2025 (NYSE:BHC) - Seeking Alpha
Bausch Health Companies Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres - Yahoo Finance
Will Bausch Health Companies Inc announce a stock splitQuarterly Market Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Bausch Health Companies Inc Azioni (BHC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.15%
3.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):